Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
55pct
9d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Medical Device Guardians Act This bill amends the Federal Food, Drug, and Cosmetic Act to require physicians to report significant adverse experiences caused by medical devices to the Food and Drug Administration.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · second_quarter · Health Issues
H.R. 1215, Protecting Access to Care Act of 2017 H.R. 2163, Medical Device Guardians Act H.R. 2164, Medical Device Safety Act S. 974, Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act of 2017 Proposed Regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to Americans with Disabilities Act (P.L. 101-336) and websites; drug and medical device preemption; medical liability reform
Client expense: $5,160,000 · Firm income: Not reported
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Securities & Exchange Commission (SEC)
2018 · second_quarter · Health Issues
Issues related to implementation of PL 115-52, the Food and Drug Administration Reauthorization Act Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. H.R. 2164 related to medical device preemption protection H.R. 2163 related to medical device reporting H.R. 2118 related to third party servicing of medical devices H.R. 1703 related to medical product communications H.R. 2026 related to medical product communications Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulating procedures for devices Issues related to cybersecurity for medical technology Issues related to procurement and acquisition policies of the VA health system for medical technology and supplies H.R. 5418 related to improving the Medical-Surgical Prime Vendor procurement program at the VA S. 1691 related to cybersecurity and government procurement Issues related to medical technology and the opioid crisis H.R. 6 related to the opioid crisis
Client expense: $740,386 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Issues related to implementation of PL 115-52, the Food and Drug Administration Reauthorization Act Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. H.R. 2164 related to medical device preemption protection H.R. 2163 related to medical device reporting H.R. 2118 related to third party servicing of medical devices H.R. 1703 related to medical product communications H.R. 2026 related to medical product communications Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulating procedures for devices Issues related to cybersecurity for medical technology Issues related to procurement and acquisition policies of the VA health system for medical technology and supplies
Client expense: $1,050,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
H.R. 1215, Protecting Access to Care Act of 2017 H.R. 2163, Medical Device Guardians Act H.R. 2164, Medical Device Safety Act Proposed Regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to Americans with Disabilities Act (P.L. 101-336) and websites; drug and medical device preemption; medical liability reform
Client expense: $7,540,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Vice President of the U.S.
2017 · fourth_quarter · Health Issues
Issues related to implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. H.R. 2164 related to medical device preemption protection H.R. 2163 related to medical device reporting H.R. 2118 related to third party servicing of medical devices H.R. 1703 related to medical product communications H.R. 2026 related to medical product communications H.R. 878 the Right to Try Act of 2017 Issues related to diagnostics regulation Issues related to diagnostics payment reform Issues related to cybersecurity for medical technology S. 1691 Internet of Things (IoT) Cybersecurity Improvement Act of 2017 H.R. 3985 Internet of Medical Things Resilience Partnership Act of 2017 H.R. 4163 and S. 2020 Cyber Shield Act of 2017 H.R. 4191 HHS Cybersecurity Modernization Act Issues related to procurement and acquisition policies of the VA health system for medical technology and supplies Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies
Client expense: $1,010,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
H.R. 1215, Protecting Access to Care Act of 2017 H.R. 2163, Medical Device Guardians Act H.R. 2164, Medical Device Safety Act Proposed Regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to drug and medical device preemption; medical liability reform
Client expense: $7,040,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
2017 · third_quarter · Health Issues
Issues related to implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act Issues related to the regulation and publication of clinical trials for medical devices Issues related to FDA public communications regarding emerging signals Issues related to implementation of the 21st Century Cures Act Issues related to the Medical Device User Fee Agreement Issues related to the competitiveness of the medical technology industry and the impact of Federal policies H.R. 2430 and S. "934" The FDA Reauthorization Act H.R. 2474 Medical Product Review Harmonization Act H.R. 2144 and SS. 1070 related to the classification of medical device accessories H.R. 2483 and S. 1183 related to modifications to medical devices S. 1069 related to postmarket regulation of medical devices H.RR. 2164 related to medical device preemption protection H.R. 2163 related to medical device reporting H.R. 2118 related to third party servicing of medical devices H.R. 1703 related to medical product communications H.R. 2026 related to medical product communications S.404 and H.R. 1736 bills to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications Issues related to diagnostics regulation Issues related to diagnostics payment reform Issues related to promoting innovation in the med tech industry and improving FDA regulating procedures for devices Issues related to cybersecurity for medical technology Issues related to procurement and acquisition policies of the VA health system for medical technology and supplies Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies Issues related to federal regulation of the distribution and supply chain for medical devices
2017 · third_quarter · Health Issues
H.R. 1215, Protecting Access to Care Act of 2017 H.R. 2163, Medical Device Guardians Act H.R. 2164, Medical Device Safety Act Proposed Regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to drug and medical device preemption; medical liability reform
Client expense: $4,890,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2017 · second_quarter · Health Issues
H.R. 1215, Protecting Access to Care Act of 2017 H.R. 2163, Medical Device Guardians Act H.R. 2164, Medical Device Safety Act Proposed Regulation regarding labeling changes for approved drugs and biological products (78 Fed. Reg. 67,985-67,999, November 13, 2013) Various issues relating to drug and medical device preemption; medical liability reform
Client expense: $3,330,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2017 · second_quarter · Health Issues
Issues related to implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act Issues related to the regulation and publication of clinical trials for medical devices Issues related to FDA public communications regarding emerging signals Issues related to implementation of the "21st Century Cures Act" Issues related to the Medical Device User Fee Agreement Issues related to the competitiveness of the medical technology industry and the impact of Federal policies H.R. 2430 and S. 934 The FDA Reauthorization Act H.R. 2474 Medical Product Review Harmonization Act H.R. 2144 and SS. 1070 related to the classification of medical device accessories H.R. 2483 and S. 1183 related to modifications to medical devices S. 1069 related to postmarket regulation of medical devices H.RR. 2164 related to medical device preemption protection H.R. 2163 related to medical device reporting H.R. 2118 related to third party servicing of medical devices H.R. 1703 related to medical product communications H.R. 2026 related to medical product communications S.404 and H.R. 1736 bills to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications Issues related to diagnostics regulation Issues related to diagnostics payment reform Issues related to promoting innovation in the med tech industry and improving FDA regulating procedures for devices Issues related to cybersecurity for medical technology Issues related to procurement and acquisition policies of the VA health system for medical technology and supplies Issues related to the regulation of and access to cancer diagnostics, imaging, and radiation therapies Issues related to AHCA/BCRA
Client expense: $760,000 · Firm income: Not reported
Client expense: $760,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE